TapImmune Inc. is a public OTC-BB biotechnology company with its core business focus on emerging technologies based on cellular immunology and genetic understanding of the cause and potential novel treatments of disease.

Corporate Governance

Financial Statements

Fiscal Year 2012
Form 10-Q September 30
Fiscal Year 2011   Form 10-K 2011 Annual Report
Fiscal Year 2010
Form 10-KSB 2010 Annual Report
Click here for a list of all previous filings
		Corporate Snapshot and Executive Summary